Quarterly Result: Divi's Laboratories Ltd.

Technical View: 

Divis Laboratories Ltd., ended at Rs. 1237.5, down by 16.65 points or 1.33% from its earlier closing of Rs. 1254.15 on the BSE.
The scrip touched a high and low of Rs. 1255.05 and Rs. 1230.3 respectively, after opening at 1247. Altogether 196523(NSE+BSE) shares have been traded on the counter; and the stock is trading above its 50 DMA.

Standalone Results Q2FY17:

Bloomberg estimates were higher than Divi’s Laboratories Ltd’s actual Q2FY17 standalone numbers. Revenue for the period has come in 10.5% higher than the estimate of Rs 1,124 cr. Reported net profit for the period has come in 26.5% lesser than the estimate of Rs 305 cr.
The quarter's revenue has soared 3.4% yoy to 1,005.
Rico's EBITDA has eroded by 22.6% yoy to Rs 291 cr while EBITDA margins have shrunken 972 bps yoy to 29%. Depletion was on account of 93% yoy surge to Rs 165 cr in employee cost (one time ex-gratia payment of Rs 79 cr) and 32% yoy surge to Rs 164 cr in other expenses. 
The company's net profit has depleted by 24.6% yoy to Rs 224 cr. This can be attributed to 32% yoy dip in other income and 15% yoy surge in finance cost.